Shortage pharmaceuticals (0015) – BPA Call to TDS Med, Inc.

Award facts

Contract value

$400,000.00 Current and potential, with all options

Completion date

Sep 30, 2016 Current and potential, with all options

NAICS code

423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

PSC

6505 Drugs And Biologicals

Set-aside

No set-aside

Competition

Competed under SAP · 1 offer Simplified Acquisition

Pricing

Firm Fixed Price

Place of performance

Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI · Apr 26, 2025

This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a defense agency, to TDS Med, Inc., a self-certified small disadvantaged business. The $400,000 contract is for the provision of shortage pharmaceuticals, including blood products, medical inhalations, injectables, and other relevant pharmaceutical products. The contract has a period of performance through September 30, 2016. This award is associated with a larger $2 million BPA contract vehicle that TDS Med, Inc. was previously awarded by DHA in September 2019 to provide pharmaceutical products and supplies. The BPA runs through September 2024, and task orders are issued under it to fulfill requirements related to shortage pharmaceuticals.

Quick answers

Who was awarded contract 0015?

0015 was awarded to TDS Med, Inc. by Defense Health Agency (Department of Defense) on August 17, 2016.

How much is contract 0015 worth?

The government has obligated $400,000 on 0015.

Is contract 0015 an order under another contract?

Yes. 0015 is a BPA call under HT001414A0004, a blanket purchase agreement.

Was contract 0015 competed?

The extent of competition for 0015 was competed under sap. The government received 1 offer.

See this award's full record

Every transaction and funding action

The awardee's other awards and teaming partners

Similar awards and recompete opportunities

Ask GovTribe AI about this award